在儿科中推进骨髓母细胞瘤治疗:综合分子分类和新兴治疗方法
David T Kim1, Michaela Uloho-Okundaye1, Stephen C Frederico2
1Harvard College, Harvard University, Cambridge, MA 02138, USA.
Brain sciences
|August 28, 2025
概括
脑髓母细胞瘤是一种常见的儿童脑瘤, 现在被分为基因子组. 了解这些独特的脑髓母细胞瘤 (MB) 亚型是开发向治疗和改善全球儿童的关键.
科学领域:
- 儿童瘤学
- 神经瘤学
- 遗传学
背景情况:
- 脑髓母细胞瘤 (MB) 是最常见的恶性儿童脑瘤.
- 最近的分类 (2021 WHO CNS5) 将MB分为不同的基因子组:WNT,SHH,3组和4组.
- 在这些MB亚组中存在显著的生物学和预后异质性.
研究的目的:
- 审查目前关于脑髓母细胞瘤亚群生物学方面的知识.
- 综合有关MB现有和新兴治疗策略的信息.
- 突出需要适应风险的方法,并解决全球护理差异.
主要方法:
- 对脑髓母细胞瘤研究的文献综述.
- 分子分析和分组分类数据的综合.
- 对当前和新型治疗策略的分析.
主要成果:
- 基于基因子组的MB表现出显著的异质性.
- 分子分析的进步指导了个性化治疗方法.
- 新兴疗法包括小组特异性抑制剂和免疫疗法.
结论:
- 将分子洞察转化为精确,少毒的脑髓母细胞瘤治疗方法至关重要.
- 应对风险的策略和解决全球差异对于公平的护理至关重要.
- 缩小分子理解与实施之间的差距将改善全球儿童脑髓母细胞瘤患者的治疗结果.
相关概念视频
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


